This inventor holds 62 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Peptide Compositions (CPC class A61K). Top assignees: Palatin Technologies Incorporated, Rhythm Pharmaceuticals, Inc., Actinium Pharmaceuticals, Limited. Active years: 1997-2026.
Inventors with similar research interests:
Location History:
- Albuquerque, NM (US) (1997 - 2000)
- Plainsboro, NJ (US) (2001 - 2006)
- Cranbury, NJ (US) (2005 - 2024)
Company Filing History:
47 out of 68 
5 out of 12 
4 out of 31 
Years Active: 1997-2026
Areas of Expertise:
Title: The Innovative Journey of Shubh D Sharma
Introduction:
Shubh D Sharma, a brilliant inventor hailing from Cranbury, NJ, has left an indelible mark in the field of medical innovations with an impressive 59 patents to his name. His groundbreaking work has significantly advanced radiotherapeutic and diagnostic interventions for various forms of lymphomas and hematopoietic malignancies.
Latest Patents:
Shubh D Sharma's latest patents include the development of stabilized radiolabeled anti-CD45 immunoglobulin compositions. These compositions serve to stabilize a radio-iodinated monoclonal IgG antibody for up to 17 days against radiolytic decomposition. The resulting stabilized radiolabeled murine antibody targets the CD45 antigen expressed on different lymphomas, proving invaluable as a therapeutic and diagnostic agent in the treatment of human malignancies of hematopoietic origin.
Career Highlights:
Having worked with esteemed companies such as Palatin Technologies Incorporated and Rhomed Incorporated, Shubh D Sharma has showcased his expertise in translating innovative ideas into tangible solutions. His dedication to pushing the boundaries of medical science has led to numerous patents that have the potential to revolutionize cancer treatment methodologies.
Collaborations:
Throughout his career, Shubh D Sharma has collaborated with exceptional peers in the industry, including the likes of Yi-Qun Shi and Wei Yang. The collective efforts of these talented individuals have paved the way for transformative advancements in the realm of medical technology and cancer therapeutics.
Conclusion:
In conclusion, Shubh D Sharma's prolific career as an inventor and innovator underscores his unwavering commitment to driving progress in the field of medical research. His remarkable contributions have not only enriched the scientific community but also offered hope to patients battling hematopoietic malignancies. Shubh D Sharma's relentless pursuit of excellence serves as an inspiration to aspiring inventors and underscores the transformative power of innovation in the realm of healthcare.